Wellspect HealthCare, a global MedTech business based in Mölndal, Sweden - and a subsidiary of Dentsply Sirona, announced this week the appointment of Chris Schlenk, as new Group Vice President.

 

Chris Schlenk has more than twenty years' experience in the medical device and life sciences industry. He has held various Marketing, Commercial Operations, and General Management roles at Becton Dickinson & Company including leadership responsibility in Diabetes, Home Care and Urology. Prior to joining Wellspect, Chris held the role of Vice President, Interventional Systems at Terumo Medical Corporation.

 

“We are very pleased to see Chris join Wellspect. Chris is an experienced executive with a proven track record and a passion for healthcare. I am confident that under Chris’s leadership Wellspect will continue to grow and make a difference in the life of patients”, said Andreas Frank, Executive Vice President and Chief Business Officer at Dentsply Sirona. 

 

Chris will be part of the Global Business Unit leadership team of Dentsply Sirona.

 

I am honored to join Wellspect HealthCare, a key player in urology and continence care and a sustainability leader. I share the Wellspect team’s passion for helping people around the world lead healthy, dignified lives and I look forward to leveraging my experience to help the organization expand and grow globally”, said Chris Schlenk.

 

Source: Wellspect HealthCare

«« Analysis of Patient Outcomes Following Long-Term Acute Care Hospital Closures


NHS Trials an AI System Aimed at Preventing Avoidable Admissions »»



Latest Articles

Vice President, Corporate News leadership medtech, Chris Schlenk, Wellspect HealthCare Wellspect HealthCare, a global MedTech business based in Mölndal, Sweden - and a subsidiary of Dentsply Sirona, announced this week the appointment of Chris Schlenk, as new Group Vice President.